Testosterone and Thrombosis
Testosterone Replacement Therapy Replacement therapy with low doses of testosterone does not adversely affect blood coagulation status [ref 1] and does not appear to increase the risk of venous or...
View ArticleClik here to view.
Athletes and DVT + PE
Background Many people think of DVT and PE as a problem occurring in elderly people, but not in young and apparently healthy individuals. While it is certainly true that they occur more commonly in the...
View ArticleApixaban (Eliquis®) – Another New Oral Anticoagulant
Good news. Another one of the new oral anticoagulants in development, Apixaban (Eliquis®), has moved forward. On May 20th, 2011, the European Medicines Agency (EMA) approved Eliquis® for DVT...
View ArticleDVT and PE: How Long to Treat With Anticoagulants?
Explanation for Patients The complex topic of “Length of Anticoagulant Treatment” for patients with VTE is being addressed in a blog entry written for patients, found on the Clot Connect patient...
View ArticleIncidentally Discovered DVT, PE or Other Clots
General comments CT or MRI scans will occasionally detect an incidental iliofemoral DVT, PE or intra-abdominal thrombosis (IVC, portal, splenic, mesenteric or renal vein). This is particularly common...
View ArticleClik here to view.
Yasmin, Yaz and Other Drospirenone Contraceptives: Risk for VTE
It has long been known that estrogen-containing birth control preparations (pill, patch, ring) increase the risk for DVT and PE (venous thromboembolism = VTE). This risk is partially due to the...
View ArticleHip and Knee Replacement Surgery – DVT Prophylaxis – AAOS Guideline
Two main guidelines exist which many physicians go by to decide whether a particular patient should get DVT prophylaxis after hip or knee replacement surgery, what method (compression device, or...
View ArticleVTE Prevention in Hospitalized Patients: New ACP Guideline
A new guideline was published this week about venous thromboembolism (VTE) prophylaxis in hospitalized medical sick patients and in stroke patients [link here; ref 1]. The key points of this guideline,...
View ArticleClik here to view.
Xarelto and DVT – Approved in Europe
Xarelto (Rivaroxaban) was approved in Europe today (Dec 19th, 2011) for patients with acute DVT. This is good news on the path to have a blood thinner for patients with DVT available that is easier to...
View ArticleNew ACCP Guidelines – DVT and PE: Highlights and Summary
Stephan Moll, MD writes… This month the American College of Chest Physicians (ACCP) published its new (2012) guidelines regarding anticoagulation and management of various thrombotic disorders,...
View Article
